BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 15879618)

  • 1. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.
    Terjung B; Spengler U
    Clin Rev Allergy Immunol; 2005 Apr; 28(2):115-33. PubMed ID: 15879618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune liver diseases.
    McFarlane IG
    Scand J Clin Lab Invest Suppl; 2001; 235():53-60. PubMed ID: 11712693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The positive rate of auto antibodies and autoimmune liver diseases in patients with abnormal liver function].
    Liu YM; Yan HP; Wang JT
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):360-2. PubMed ID: 15225434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do autoantibodies predict autoimmune liver disease in primary Sjögren's syndrome? Data of 180 patients upon a 5 year follow-up.
    Csepregi A; Szodoray P; Zeher M
    Scand J Immunol; 2002 Dec; 56(6):623-9. PubMed ID: 12472675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma.
    Kinoshita H; Omagari K; Whittingham S; Kato Y; Ishibashi H; Sugi K; Yano M; Kohno S; Nakanuma Y; Penner E; Wesierska-Gadek J; Reynoso-Paz S; Gershwin ME; Anderson J; Jois JA; Mackay IR
    Liver; 1999 Apr; 19(2):122-8. PubMed ID: 10220742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune hepatitis and overlap syndromes.
    Dienes HP; Erberich H; Dries V; Schirmacher P; Lohse A
    Clin Liver Dis; 2002 May; 6(2):349-62, vi. PubMed ID: 12122860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoantibodies in hepatology].
    Johanet C; Dubel L; Chazouillères O
    Pathol Biol (Paris); 1999 Nov; 47(9):997-1005. PubMed ID: 10609280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis.
    Csepregi A; Obermayer-Straub P; Kneip S; Kayser A; Loges S; Schmidt E; Nemesánszky E; Szalay F; Manns MP; Strassburg CP
    Clin Dev Immunol; 2003; 10(2-4):173-81. PubMed ID: 14768949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.
    Boberg KM; Aadland E; Jahnsen J; Raknerud N; Stiris M; Bell H
    Scand J Gastroenterol; 1998 Jan; 33(1):99-103. PubMed ID: 9489916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
    Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
    Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantigens in primary biliary cirrhosis.
    Jones DE
    J Clin Pathol; 2000 Nov; 53(11):813-21. PubMed ID: 11127262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.
    Xu B; Broome U; Ericzon BG; Sumitran-Holgersson S
    Gut; 2002 Jul; 51(1):120-7. PubMed ID: 12077104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatitic/cholestatic "overlap" syndrome: an Italian experience.
    Muratori L; Cassani F; Pappas G; Guidi M; Mele L; Lorenza V; Lenzi M; Bianchi FB; Muratori P
    Autoimmunity; 2002 Dec; 35(8):565-8. PubMed ID: 12765484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis?
    Comay D; Cauch-Dudek K; Hemphill D; Diamandis E; Wanless I; Heathcote EJ
    Dig Dis Sci; 2000 Oct; 45(10):2018-21. PubMed ID: 11117577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlation of antimitochondrial antibodies.
    Zuber MA; Recktenwald C
    Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antilactoferrin antibodies in autoimmune liver disease.
    Muratori L; Muratori P; Zauli D; Grassi A; Pappas G; Rodrigo L; Cassani F; Lenzi M; Bianchi FB
    Clin Exp Immunol; 2001 Jun; 124(3):470-3. PubMed ID: 11472410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.